Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CEO | Patel Snehal | Jul 29, 2026 | Buy | $9.17K | 700 |
| CEO | Patel Snehal | Jul 28, 2026 | Buy | $20.39K | 1,500 |
| CEO | Patel Snehal | Jul 27, 2026 | Buy | $20.43K | 1,500 |
| CEO | Patel Snehal | Jul 24, 2026 | Buy | $14.17K | 1,100 |
| CEO | Patel Snehal | Jul 23, 2026 | Buy | $32.85K | 2,500 |
| CEO | Patel Snehal | Jan 13, 2026 | Buy | $53.69K | 1,800 |
| CEO | Patel Snehal | Jan 12, 2026 | Buy | $79.87K | 2,900 |
| CEO | Patel Snehal | Dec 31, 2025 | Buy | $91.85K | 4,300 |
| CEO | Patel Snehal | Dec 30, 2025 | Buy | $63.02K | 2,900 |
| CEO | Patel Snehal | Dec 18, 2025 | Buy | $51.74K | 4,100 |
| CEO | Patel Snehal | Nov 25, 2025 | Buy | $38.5K | 4,600 |
| CEO | Patel Snehal | Nov 7, 2025 | Buy | $89.36K | 10,600 |
| CEO | Patel Snehal | Oct 31, 2025 | Buy | $21.3K | 2,300 |
| CEO | Patel Snehal | Apr 25, 2025 | Buy | $35.57K | 3,600 |
| CEO | Patel Snehal | Apr 17, 2025 | Buy | $48.49K | 5,400 |
| CEO | Patel Snehal | Apr 7, 2025 | Buy | $32.76K | 3,600 |
| CEO | Patel Snehal | Apr 4, 2025 | Buy | $48.02K | 5,500 |
| CEO | Patel Snehal | Jan 10, 2025 | Buy | $31.28K | 2,500 |
| CEO | Patel Snehal | Jan 7, 2025 | Buy | $24.75K | 1,800 |
| CEO | Patel Snehal | Jan 6, 2025 | Buy | $14.64K | 1,100 |
| CEO | Patel Snehal | Jan 3, 2025 | Buy | $44.03K | 3,400 |
| CEO | Patel Snehal | Jan 2, 2025 | Buy | $23.94K | 2,000 |
| CEO | Patel Snehal | Dec 31, 2024 | Buy | $27.26K | 2,400 |
| CEO | Patel Snehal | Dec 30, 2024 | Buy | $35.58K | 3,200 |
| VP Clinical Reg Affairs | Thompson Jaye | Nov 21, 2024 | Buy | $12.91K | 1,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
